Document is current
Any future updates will be listed below
-
Authors
Distler, Jörg H. W. https://orcid.org/0000-0001-7408-9333
Györfi, Andrea-Hermina https://orcid.org/0000-0002-4960-3369
Ramanujam, Meera
Whitfield, Michael L.
Königshoff, Melanie
Lafyatis, Robert
- License Information
-
More Information
Article History
Accepted: 3 October 2019
First Online: 11 November 2019
Competing interests
: J.H.W.D. declares that he has consultancy relationships and/or has received research funding from Actelion, Active Biotech, Array Biopharma, Bayer Pharma, Boehringer Ingelheim, BMS, Celgene, GSK, JB Therapeutics, Novartis, Sanofi-Aventis and UCB in the area of potential treatments for systemic sclerosis, and owns stock in 4D Science GmbH. M.R. declares that she is an employee of Boehringer-Ingelheim. The other authors declare no competing interests.
